Ask an expert

Authorisation holders

NOBEL Pharma Schweiz AG: Swissmedic authorisations

NOBEL Pharma Schweiz AG is registered with Swissmedic as the authorisation holder of 43 medicines. The most common category is Synthetic medicines. The list below shows every authorisation with its number and dispensing category.

  • Synthetic medicines43

All medicines from NOBEL Pharma Schweiz AG

Afelor Liquid Caps 200 mgAuthorisation number 69402 · ATC M01AE01DAfelor Lysinat 200 mgAuthorisation number 69416 · ATC M01AE01DAfenadin 120Authorisation number 69487 · ATC R06AX26DApixaban NOBEL 2.5 mgAuthorisation number 69829 · ATC B01AF02BAripiprazol NOBEL 1 mg/mlAuthorisation number 67743 · ATC N05AX12BAripiprazol NOBEL 5 mgAuthorisation number 67607 · ATC N05AX12BAtorvastatin NOBEL 10 mgAuthorisation number 69098 · ATC C10AA05BBisoprolol NOBEL 2.5 mgAuthorisation number 67933 · ATC C07AB07BDeferasirox NOBEL 90 mgAuthorisation number 67681 · ATC V03AC03BDonepezil NOBEL lingual 5 mgAuthorisation number 68060 · ATC N06DA02BDuloxetin NOBEL 30 mgAuthorisation number 67645 · ATC N06AX21BDuloxetin NOBEL uro 20 mgAuthorisation number 68564BEdoxaban NOBEL 15 mgAuthorisation number 70146 · ATC B01AF03BEltrombopag NOBEL 12.5 mgAuthorisation number 69450 · ATC B02BX05AEscitalopram NOBEL 10 mgAuthorisation number 67544 · ATC N06AB10BEtodolac NOBEL retard 600 mgAuthorisation number 68635 · ATC M01AB08BFexofenadin NOBEL 120Authorisation number 70080DFinasterid NOBELAuthorisation number 70084 · ATC D11AX10BLinagliptin NOBEL 5mgAuthorisation number 70123 · ATC A10BH05BMacitentan NOBEL 10 mgAuthorisation number 69835 · ATC C02KX04BMemantin NOBEL 10 mgAuthorisation number 68241Bneotylol GrippeAuthorisation number 69767 · ATC N02BE51Dneotylol Grippe ClassicAuthorisation number 67413 · ATC N02BE51Dneotylol Muco 600 mgAuthorisation number 68853 · ATC R05CB01DNitisinon NOBEL 4 mg/mlAuthorisation number 68332 · ATC A16AX04BNitisinon NOBEL 5 mgAuthorisation number 68331 · ATC A16AX04BPantacido 20 mgAuthorisation number 69376 · ATC A02BC02DPantoprazol NOBEL 20 mgAuthorisation number 67644 · ATC A02BC02BQuetiapin NOBEL 25 mgAuthorisation number 70266 · ATC N05AH04BRasagilin NOBEL 1 mgAuthorisation number 67711 · ATC N04BD02BRivaroxaban NOBEL 10 mgAuthorisation number 68009 · ATC B01AF01BRivaroxaban NOBEL vascular 2.5 mgAuthorisation number 68021 · ATC B01AF01BRosuvastatin NOBEL 5 mgAuthorisation number 67605 · ATC C10AA07BRyaltris 25 μg / 600 μgAuthorisation number 69672 · ATC R01AD59BSapropterin NOBEL 100 mgAuthorisation number 69374 · ATC A16AX07BSildenafil NOBEL 25 mgAuthorisation number 67646 · ATC G04BE03BSitagliptin Metformin NOBEL 50 mg/500 mgAuthorisation number 68967 · ATC A10BD07BSitagliptin NOBEL 25 mgAuthorisation number 68680 · ATC A10BH01BSolifenacin NOBEL 5 mgAuthorisation number 67838 · ATC G04BD08BTadalafil NOBEL 5 mgAuthorisation number 69811 · ATC G04BE08BTicagrelor NOBEL 60 mgAuthorisation number 69294 · ATC B01AC24BVildagliptin Metformin NOBEL 50 mg/500 mgAuthorisation number 69069 · ATC A10BD08BVildagliptin NOBEL 50 mgAuthorisation number 68750 · ATC A10BH02B

Frequently asked questions

How many medicines does NOBEL Pharma Schweiz AG have authorised in Switzerland?

43 medicines, data as of 01 September 2026. The count covers human medicine authorisations in the Swissmedic export, not individual pack sizes.

What does an authorisation holder do?

The authorisation holder applies for the authorisation, maintains it, owns the product information, reports adverse reactions to Swissmedic and keeps the product available. Under Art. 10 TPA it must have a registered office in Switzerland.

Can an authorisation be transferred?

Yes. The transfer of an authorisation to a new holder is notified to Swissmedic and carries a fee. Product information, packaging material and pharmacovigilance responsibility transfer with it.

Dispute this entry

We are happy to correct entries. Send us a note through the form, we check it against the current Swissmedic export and update the record.

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com

Sources

Swissmedic data as of 01 September 2026

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com